Skip to content
Lower risk Medical device recall · FDA · Published February 3, 2022

Abbott Alinity s System Software Version 2.8.0 Recall: Incorrect Wash Buffer Usage

Abbott recalls Alinity s System software version 2.8.0 (serials AS1001-AS1368) due to wash buffer error causing potential inaccurate test results. This is an in vitro diagnostic device.

🇺🇸 FDA recall #Z-0749-2022Medical deviceAbbott ›
Take action

Contact the company

Recalling firmAbbott Laboratories, Inc1921 Hurd Dr · Irving, TX 75038-4313
✎ GovInfoNow plain-language explainer

What happened, in plain English

Abbott is recalling Alinity s System software version 2.8.0 for a wash buffer error that uses 1 mL instead of 3 mL of buffer. This could lead to inaccurate test results for in vitro diagnostics. Read more at govinfonow.com/recall/61183-abbott-alinity-s-system-software-version-2-8-0-recall.

Source Summary by GovInfoNow · govinfonow.com/recall/61183-abbott-alinity-s-system-software-version-2-8-0-recall · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0749-2022

Cite this page

“Abbott Alinity s System Software Version 2.8.0 Recall: Incorrect Wash Buffer Usage.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61183-abbott-alinity-s-system-software-version-2-8-0-recall. Based on FDA recall #Z-0749-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0749-2022%22&limit=1).

Why it’s dangerous

The software error causes the system to use 1 mL of wash buffer instead of the required 3 mL during the probe wash cycle. This incorrect buffer usage can lead to inaccurate test results for in vitro diagnostic tests.

Who’s affected

Users of the Alinity s System (serial numbers AS1001 through AS1368) who perform in vitro diagnostic tests may be affected. Healthcare professionals using this device for lab testing are most at risk.

How to tell if you have this one

Check if your Alinity s System has software version 2.8.0, identified by serial numbers AS1001 through AS1368. The device is intended for in vitro diagnostic use only.

  • Brand
    Abbott
  • Product
    Alinity s System software version2.8.0, REF LN 06P16-01, IVD, OEI: (01)00380740138479 The Alinity s System is intended
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Update Software

    Contact Abbott to update to the corrected software version 2.8.1 or later.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 17 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: nationwideMINew York: nationwideNYRhode Island: named in the noticeRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: nationwideOHPennsylvania: named in the noticePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: nationwideFL

FDA distribution: “Worldwide distribution: US (nationwide) including states of: AL, CA, GA, IL, IN, MN, MO, NC, OK, PA, RI, SC, TN, TX, WA, WI, MD and countries (OUS) including of: Australia, Austria, Bahrain, Belgium, Brazil, china, Colombia, Croatia,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, California, Georgia, Illinois, Indiana, Maryland, Minnesota, Missouri, North Carolina, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Washington, Wisconsin.

Recall timeline

FDA published this recall 48 days after the firm started it.

1. Firm started the recall: Feb 3, 202212. FDA classified it Class II: Mar 11, 202223. Published in FDA’s Enforcement Report: Mar 23, 202232022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0749-2022 (February 3, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0749-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA